Logotype for Narayana Hrudayalaya Limited

Narayana Hrudayalaya (NH) Q2 26/27 earnings summary

Event summary combining transcript, slides, and related documents.

Logotype for Narayana Hrudayalaya Limited

Q2 26/27 earnings summary

2 Nov, 2026

Executive summary

  • Q2 FY27 consolidated revenue was ₹28,439.89m, up 73.0% YoY; EBITDA was ₹6,054.15m and continuing-operations net profit ₹3,011.53m.

  • India hospital growth was driven by higher volumes and price mix; management prioritizes patient access and volume over targeting a specific margin.

  • International operations are pursuing cost efficiencies and integrated care, with UK revenue recovery and insurance profitability key execution priorities.

  • H1 FY27 consolidated revenue was ₹55,276.23m, EBITDA ₹11,105.93m and continuing-operations net profit ₹5,084.23m.

Financial highlights

  • Q2 consolidated EBITDA was ₹6,054.15m, up 42.0% YoY; EBITDA margin was 21.3% versus 25.9% in Q2 FY26.

  • Continuing-operations net profit was ₹3,011.53m versus ₹2,584.95m a year earlier; net profit margin was 10.59% versus 15.71%.

  • India hospital EBITDA margin was 26.8%, or 23.6% excluding other income; doctor and nursing costs fell 1.8% through operating leverage.

  • India inpatient volumes rose 4% YoY and outpatient footfall 12% YoY; inpatient footfall was up 6% QoQ and nearly 4% YoY.

  • Combined India insurance and clinic losses fell to INR 20 crore from INR 33 crore in the prior quarter; India insurance reported a ₹151m PAT loss in Q2.

Outlook and guidance

  • Management expects stronger India inpatient and outpatient footfalls in Q3 and Q4, supported by recent volumes and patient funnels across regions.

  • India average length of stay is targeted to move toward 4.0–4.1 days over four to six quarters, subject to high-acuity and transplant case mix.

  • UK returns should be assessed over five to seven years; management expects to bridge the 4%–5% group ROCE dilution from the UK over roughly five years.

  • Cayman plans major insurance repricing in July 2027 and expects to exit most unprofitable books from then; losses are expected to become negligible before that.

  • Bed capacity target is 7,800+ by FY30; FY27 capex plans are ₹4,600m for greenfield/inorganic projects and ₹2,700m for replacement and maintenance.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
All investor relations material. One API.
Learn more

Latest events from Narayana Hrudayalaya